Lisata Therapeutics, Inc. (LSTA) earnings
LSTA earnings moved a median of -0.01% by the close. Quarterly and annual LSTA reports and results, each read against the price at its own news timestamp. Back to the LSTA overview →
25 measured LSTA earnings events.
Where these LSTA earnings landedvs 24 measured LSTA earnings reactions
| Middle 50% of LSTA earnings reactions | -2.79% to +1.55% |
|---|---|
| Median reaction (to close) | -0.01% |
| Measured reactions | 24 |
Point-in-time · zero look-ahead
Half of the 24 LSTA earnings events with a measured close landed between -2.79% and +1.55%; 50% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q LISATA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q LISATA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | — | +0.95% | |
| Form 10-Q LISATA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +1.88% | |
| Form 10-K/A LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +1.56% | +0.63% | |
| Form 10-K LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.40% | +0.40% | |
| Form 10-Q LISATA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -0.94% | -3.29% | |
| Lisata Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | -0.94% | -3.29% | |
| Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025 | Press release | +6.92% | +2.30% | |
| Form 10-Q LISATA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.26% | |
| Lisata Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -2.26% | |
| Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025 | Press release | +1.22% | +0.81% | |
| Form 10-Q LISATA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -12.13% | |
| Lisata Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | +0.00% | -12.13% | |
| Lisata Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update on Thursday, May 8, 2025 | Press release | +0.00% | -0.41% | |
| Form 10-K LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +0.00% | +3.03% | |
| Form 10-Q LISATA THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -2.79% | |
| Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update | Press release | +0.00% | -2.79% | |
| Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024 | Press release | — | +1.39% | |
| Form 10-Q LISATA THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -2.00% | |
| Lisata Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update | Press release | +0.00% | -2.00% | |
| Lisata Therapeutics to Report Second Quarter 2024 Financial Results and Provide a Business Update on Monday, August 12, 2024 | Press release | +0.00% | -5.48% | |
| Form 10-Q LISATA THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -0.17% | +1.55% | |
| Lisata Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update | Press release | -0.17% | +1.55% | |
| Lisata Therapeutics to Report First Quarter 2024 Financial Results and Provide a Business Update on Thursday, May 9, 2024 | Press release | — | +4.64% | |
| Form 10-K LISATA THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | +9.18% | +5.44% |
Keep exploring
More LSTA: analyst actions → · SEC filings → · LSTA overview →